Evidence map›Paper›PMID 28880838›Full record

ArticlePreventing chronic disease2017

Aspirin for Prevention of Cardiovascular Disease.

Vincent L Mendy, Rodolfo Vargas, Lei Zhang

Open access · diamondAbstract read
In one paragraph

Article in Preventing chronic disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Vincent L MendyOffice of Health Data and Research, Mississippi State Department of Health, 570 East Woodrow Wilson Drive, Jackson, MS 39215. Email: vincent.mendy@msdh.ms.gov.
Rodolfo VargasOffice of Health Data and Research, Mississippi State Department of Health, Jackson, Mississippi.
Lei ZhangOffice of Health Data and Research, Mississippi State Department of Health, Jackson, Mississippi.
Mississippi State Department of Health · US

Funding

Mississippi Delta Health Collaborative U50DP003088 · DP · MISSISSIPPI STATE DEPARTMENT OF HEALTH · PI SUTTON, VICTOR D · 2010 to 2014
$16.7M
NCCDPHP CDC HHS U50 DP003088
6 · The paper itself

Abstract

We used data from the 2013 Mississippi Behavioral Risk Factor Surveillance System to examine aspirin use for the prevention of primary and secondary cardiovascular disease (CVD), based on the 2009 US Preventive Services Task Force (USPSTF) guidelines, among Mississippi men (aged 45-79 y) and women (aged 55-79 y) and to explore differences in aspirin use by sociodemographic characteristics. Among those without CVD, 39.1% of men and 45.9% of women reported taking aspirin, and among those with CVD, 85.9% of men and 85.1% of women reported taking aspirin. Data on preventive use of aspirin by sociodemographic characteristics yielded mixed results.

Indexed as

AgedAspirinCardiovascular DiseasesFibrinolytic AgentsHumansMaleMiddle AgedMississippiAspirinFibrinolytic Agents

Identifiers

PMID28880838
PMCPMC5590489
OpenAlexW2750629834

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.